製藥業

Probe into graft traps Chinese drug group

Beijing has taken the first step to extend its probe of pharmaceutical corruption in China to domestic drug companies, with state television broadcasting claims that a Chinese drug company bribed doctors with overseas trips.

Chia Tai Tianqing Pharmaceutical Group said yesterday it had set up a team to investigate allegations in a report by CCTV that sales teams based in the eastern province of Jiangsu treated doctors to free travel to Thailand and Taiwan in return for their attendance at an hour-long information session about their drugs. The company is 60 per cent owned by Hong Kong-listed Sino Biopharmaceutical.

It was the first time that Chinese official media had named a local company in connection with alleged pharmaceutical corruption.

您已閱讀29%(749字),剩餘71%(1846字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×